You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

navtemadlin

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Endometrial Cancer Trial (Navtemadlin, Navtemadlin Placebo)

Not yet recruiting
  • Endometrial Cancer
  • Navtemadlin
  • Navtemadlin Placebo
  • (no location specified)
Mar 21, 2023

Non Small Cell Lung Cancer Trial (Navtemadlin, Navtemadlin Placebo, Pembrolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Navtemadlin
  • +2 more
  • (no location specified)
Jan 27, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

Recruiting
  • Merkel Cell Carcinoma
  • Aurora, Colorado
  • +38 more
Aug 3, 2022

Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

Recruiting
  • Resectable Soft Tissue Sarcoma
  • Soft Tissue Sarcoma
  • Navtemadlin
  • Radiation Therapy
  • Goodyear, Arizona
  • +52 more
Jul 21, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma, Small Cell Lung Cancer Extensive Stage Trial in Worldwide (KRT-232)

Recruiting
  • Small-cell Lung Cancer
  • +3 more
  • Fort Myers, Florida
  • +29 more
Jun 15, 2022

Acute Myeloid Leukemia Trial in Worldwide (TL-895, KRT-232)

Recruiting
  • Acute Myeloid Leukemia
  • Los Angeles, California
  • +33 more
Aug 3, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF), Post-Essential Thrombocythemia Myelofibrosis

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Glendale, California
  • +28 more
May 5, 2022

Chronic Myeloid Leukemia Trial in Worldwide (KRT-232, Dasatinib, Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Birmingham, Alabama
  • +25 more
Mar 4, 2022

Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis Trial in Worldwide (KRT-232, TL-895)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +36 more
May 5, 2022

Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Goshen, Indiana
  • +44 more
Aug 3, 2022

Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in

Recruiting
  • Primary Myelofibrosis (PMF)
  • +2 more
  • Birmingham, Alabama
  • +155 more
Aug 12, 2022